ANCA positive crescentic glomerulonephritis outcome in a Central East European cohort: a retrospective study

Article English OPEN
Andreiana, Iuliana; Stancu, Simona; Avram, Andreea; Taran, Ludmila; Mircescu, Gabriel;
(2015)
  • Publisher: Springer Nature
  • Journal: BMC Nephrology,volume 16 (issn: 1471-2369, eissn: 1471-2369)
  • Related identifiers: pmc: PMC4486444, doi: 10.1186/s12882-015-0091-8
  • Subject: Nephrology | Research Article | ANCA | Pauci-immune glomerulonephritis | Histopathological classes | Outcome

Background The recently suggested distinct pathogenic pathways for myeloperoxidase (MPO) and proteinase 3 (PR3) anti-neutrophilic cytoplasmic antibodies (ANCA) associated vasculitis could result in different modes of presentation and outcome. Moreover, kidney outcome wa... View more
  • References (42)
    42 references, page 1 of 5

    1. Booth AD, Almond MK, Burns A, Ellis P, Gaskin G, Neild GH, et al. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis. 2003;41(4):776-84.

    2. Westman KW, Selga D, Isberg PE, Bladström A, Olsson H. High proteinase 3-anti-neutrophil cytoplasmic antibody (ANCA) level measured by the capture enzyme-linked immunosorbent assay method is associated with decreased patient survival in ANCA-associated vasculitis with renal involvement. J Am Soc Nephrol. 2003;14(11):2926-33.

    3. Flossmann O, Berden A, de Groot K, Hagen C, Harper L, Heijl C, et al. Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis. 2011;70(3):488-94.

    4. Franssen CF, Gans RO, Arends B, Hageluken C, ter Wee PM, Gerlag PG, et al. Differences between anti-myeloperoxidase- and anti-proteinase 3-associated renal disease. Kidney Int. 1995;47(1):193-9.

    5. Jennette JC, Falk RJ. Small-Vessel Vasculitis. N Engl J Med. 1997;337:1512-23.

    6. Fatma LB, El Ati Z, Lamia R, Aich DB, Madiha K, Wided S, et al. Alveolar hemorrhage and kidney disease: characteristics and therapy. Saudi J Kidney Dis Transpl. 2013;24(4):743-50.

    7. Hruskova Z, Casian AL, Konopasek P, Svobodova B, Frausova D, Lanska V, et al. Long-term outcome of severe alveolar haemorrhage in ANCA-associated vasculitis: a retrospective cohort study. Scand J Rheumatol. 2013;42(3):211-4.

    8. Lee T, Gasim A, Derebail VK, Chung Y, McGregor JG, Lionaki S, et al. Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure. Clin J Am Soc Nephrol. 2014;9(5):905-13.

    9. de Joode AAE, Sanders JSF, Stegeman CA. Renal Survival in Proteinase 3 and Myeloperoxidase ANCA-Associated Systemic Vasculitis. Clin J Am Soc Nephrol. 2013;8:1709-17.

    10. Millet A, Pederzoli-Ribeil M, Guillevin L, Witko-Sarsat V, Mouthon L. Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group? Ann Rheum Dis. 2013;72(8):1273-9.

  • Similar Research Results (1)
  • Metrics
    No metrics available
Share - Bookmark